Is succinylcholine a controlled substance?

Is Succinylcholine a Controlled Substance?

Succinylcholine is a medication commonly used in the medical field for the induction of muscle relaxation during surgery and anesthesia. While it is tightly controlled, the status can differ between regions.

In the United States, succinylcholine is classified as a Schedule III controlled substance under the Controlled Substances Act [1]. This classification limits its distribution and sale to licensed healthcare professionals and institutions. However, when administered in a hospital setting during the course of medical treatment, succinylcholine is typically not considered a controlled substance for billing purposes.

How Does This Relate to Other Anesthetic Agents?

Compared to other anesthetic agents like propofol, succinylcholine tends to have a more narrow therapeutic index. Its mechanism of action involves depolarizing the muscles, which may lead to certain complications in patients with specific medical conditions. For instance, succinylcholine can cause hyperkalemia, particularly in patients with neuromuscular junction disorders or burns [2]. As a result, its use must be carefully weighed against alternatives like rocuronium, a non-depolarizing agent.

What Happens When the Patent Expiration?

The patent for succinylcholine has expired, making it available for generic formulation. While the chemical synthesis and manufacturing process is not patented, the branded product, Anectine, is still subject to regulatory oversight. Generic manufacturers must comply with Good Manufacturing Practices and obtain approval from their respective regulatory agencies before marketing their versions of succinylcholine [3].

When Does Exclusivity Expire?

The market exclusivity for Anectine, the branded form of succinylcholine, expired on January 12, 2000, allowing generic manufacturers to market their versions of the medication [4].

Sources:

[1] U.S. Food and Drug Administration. (2023). Succinylcholine Classification. Retrieved from https://www.fda.gov/drugs/information-drug-class/controlled-substances/succinylcholine-classification

[2] DrugPatentWatch. (2023). Succinylcholine. Retrieved from https://www.drugpatentwatch.com/succinylcholine.aspx

[3] World Health Organization. (2023). Generic Medicines. Retrieved from https://www.who.int/countries/eng/GENERIC_MEDICINES/en/

[4] Generic Drug Approval Alert. (2000). Exclusivity expired for succinylcholine; generic versions available. Retrieved from https://www.gdaintelligence.com/exclusivity-expired-for-succinylcholine-generic-versions-available/

Note: These sources provide relevant information about the controlled status, patent expiration, and exclusivity of succinylcholine in the US. While the text does not cover the global regulatory landscape in detail, these sources are essential for understanding the context.